株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CountryFocus:台湾の医療・規制・医療費償還制度の情勢

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Taiwan

発行 GlobalData 商品コード 304732
出版日 ページ情報 英文 191 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.19円で換算しております。
Back to Top
CountryFocus:台湾の医療・規制・医療費償還制度の情勢 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Taiwan
出版日: 2017年08月17日 ページ情報: 英文 191 Pages
概要

当レポートでは、台湾の医療・規制・医療費償還制度について調査分析し、医薬品・医療機器市場の概要、医療費償還制度とその関連情報、規制当局の構造や規制の概要、国の情勢について検証するほか、市場機会や課題などについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
  • 医療機器市場
  • 市場促進要因・障壁

第4章 市場参入

  • 医療費償還・保険料払込者の情勢
  • 規制情勢

第5章 国の分析

  • 政策環境
  • 経済情勢
  • 経済指標
  • 人口統計
  • 医療インフラ
  • 産業団体
  • 見本市

第6章 機会と課題

  • 機会
  • 課題

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0080CHR

In 2016, the pharmaceutical market of Taiwan was valued at an estimated US$2.42 Billion, and is projected to reach US$2.44 Billion in 2021. The pharmaceutical market grew at a Compound Annual Growth Rate (CAGR) of 0.12% from 2009 to 2016. The government is taking various steps to ensure the growth of the pharmaceutical industry, and has proposed a budget of US$340m for turning Taiwan into an Asian Research and Development (R&D) center. According to the Act for the Development of Biotech and New Pharmaceuticals Industry, the government is providing incentives for new pharmaceutical companies, such as reductions in income tax.

Taiwanese market for medical devices is one of the largest in Asia due to the growing elderly population and consequent increase in demand for healthcare products and services. It was valued at US$1.66 Billion in 2009 and grew at a CAGR of 5% to US$2.27 Billion in 2016. By 2021, it is expected to reach US$2.95 Billion.

Taiwan has a compulsory NHI system that covers about 99% of the population (NHI, 2016). The second-generation NHI system was implemented in January 2013, and in July 2013 the name Bureau of NHI was changed to National Health Insurance Administration (NHIA). Owing to the reforms in the NHIA system, the NHIA no longer has a deficit in funding. The government is planning to initiate a third-generation NHI, which may take six to eight years to complete.

Taiwan plays a leading role as global trade and investment hub primarily due to its strategic location within the Asia-Pacific. With international shipping lanes, five free-trade zones, a modern financial sector and expertise in high-technology production, Taiwan is one of the world's top destinations for investment in terms of ease of doing business, economic freedom, and competitiveness (US DoS, 2015).

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Taiwan" is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Taiwan. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

In particular, this report provides the following -

  • Provides an overview of the pharmaceutical and medical device market of Taiwan, including the market size; market segmentation.
  • Covers the country's reimbursement and payer landscape, as well as the regulatory landscape. The reimbursement and payer landscape section elaborates on the features of the healthcare reimbursement process for Taiwan.
  • Provides a detailed analysis of the political and economic environment of Taiwan. It analyzes its economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • Provides an overview of the opportunities and challenges for growth that exist in the healthcare market of Taiwan.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Taiwan, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: China Chemical & Pharmaceutical Co., Yung Shin Pharma, TTY Biopharm, Standard Chem & Pharm Co., and Taiwan Biotech; and of major players in the medical device market: Baxter International, Fresenius, Osstem Implant, Nobel Biocare, and Ivoclar Vivadent
  • An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country's political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Taiwanese healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Taiwan's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Taiwan's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Executive Summary 9

3 Introduction 14

  • 3.1 GlobalData Report Guidance 14

4 Overview of Pharmaceutical and Medical Device Markets 15

  • 4.1 Pharmaceutical Market 15
    • 4.1.1 Market Overview 15
    • 4.1.2 Pharmaceutical Exports and Imports 18
    • 4.1.3 Supply Channels 19
    • 4.1.4 Market Segments 19
    • 4.1.5 Overview of Top Five Disease Areas 22
    • 4.1.6 Major Players 24
  • 4.2 Medical Device Market 42
    • 4.2.1 Market Overview 42
    • 4.2.2 Overview of Top Five Segments 44
    • 4.2.3 Major Players 55
  • 4.3 Market Drivers and Barriers 75
    • 4.3.1 Drivers 75
    • 4.3.2 Barriers 75

5 Market Access 77

  • 5.1 Overview of Healthcare system 77
    • 5.1.1 Reimbursement Process 79
    • 5.1.2 Overview of Insurance Providers 82
    • 5.1.3 Patient Share in Healthcare Expenditure 87
    • 5.1.4 Price Trends in the Healthcare Sector 88
    • 5.1.5 Pricing Policies 89
  • 5.2 Regulatory Landscape 89
    • 5.2.1 Overview of Regulatory Agencies 89
    • 5.2.2 Market Authorization Procedure for Pharmaceutical Products 91
    • 5.2.3 Market Authorization Procedure for Medical Devices 96
    • 5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 101
    • 5.2.5 Licensing Process for Pharmaceutical Exports and Imports 104
    • 5.2.6 Intellectual Property Rights 105
    • 5.2.7 Clinical Trial Regulations 107
    • 5.2.8 Pharmaceutical Advertising Regulations 109
    • 5.2.9 Pharmacy Regulations 110
    • 5.2.10 Labeling and Packaging Regulations 110

6 Country Analysis 112

  • 6.1 Political Environment 112
    • 6.1.1 Political Structure 112
    • 6.1.2 Current Political Environment 113
    • 6.1.3 Healthcare Policy Initiatives 114
  • 6.2 Economic Landscape 116
  • 6.3 Economic Indicators 118
    • 6.3.1 Gross Domestic Product 118
    • 6.3.2 Gross National Income 122
    • 6.3.3 Inflation 123
    • 6.3.4 Currency Exchange Rate 127
    • 6.3.5 Foreign Direct Investment 128
    • 6.3.6 Foreign Exchange Reserves 129
    • 6.3.7 Trade Balance 130
    • 6.3.8 Government Structural Balance 132
    • 6.3.9 Government Net Debt 133
    • 6.3.10 Major Industries 134
  • 6.4 Demographics 136
    • 6.4.1 Population 136
    • 6.4.2 Education and Literacy 149
    • 6.4.3 Employment 151
    • 6.4.4 Disease Burden 153
  • 6.5 Healthcare Infrastructure 154
    • 6.5.1 Healthcare Facilities 154
    • 6.5.2 Healthcare Parameters 163
    • 6.5.3 Environmental Health 165
    • 6.5.4 Healthcare Personnel 167
  • 6.6 Healthcare Expenditure 170
    • 6.6.1 Overview 170
    • 6.6.2 Share of Public and Private Sectors 171
  • 6.7 Trade Associations 172
    • 6.7.1 Taiwan Medical and Biotech Industry Association 172
    • 6.7.2 Taiwan Public Health Association 172
    • 6.7.3 Taiwan Medical Association 172
    • 6.7.4 Taiwan Generic Pharmaceutical Association 172
  • 6.8 Trade Fairs 173

7 Opportunities and Challenges 174

  • 7.1 Opportunities 174
  • 7.2 Challenges 175

8 Appendix 176

  • 8.1 Abbreviations 176
  • 8.2 Bibliography 178
  • 8.3 Research Methodology 189
    • 8.3.1 Coverage 189
    • 8.3.2 Secondary Research 190
    • 8.3.3 Forecasts 190
    • 8.3.4 Expert Panel 190
  • 8.4 Contact Us 191
  • 8.5 Disclaimer 191

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009-2016 16
  • Table 2: Pharmaceutical Market, Taiwan, Revenue ($bn), 2017-2021 17
  • Table 3: Pharmaceutical Market, Taiwan, Exports and Imports ($bn), 2009-2016 18
  • Table 4: Pharmaceutical Market, Taiwan, Revenue by Major Therapeutic Areas ($bn), 2014 22
  • Table 5: Major Products, CCPC, Taiwan, 2016 25
  • Table 6: Pharmaceutical Market, Standard, Taiwan, Major Products, 2016 35
  • Table 7: Pharmaceutical Market, Taiwan Biotech, Taiwan, Major Products, 2016 40
  • Table 8: Medical Device Market, Taiwan, Revenue ($bn), 2009-2016 42
  • Table 9: Medical Device Market, Taiwan, Revenue ($bn), 2017-2021 43
  • Table 10: Medical Device Market, Taiwan, Revenue ($m) and Market Share (%) by Segment, 2016 44
  • Table 11: Orthopedic Devices Market, Taiwan, Revenue ($m), 2009-2016 45
  • Table 12: Orthopedic Devices Market, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2016 46
  • Table 13: Healthcare IT Device Market, Taiwan, Revenue ($m), 2009-2016 47
  • Table 14: Healthcare IT Devices, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015 48
  • Table 15: Ophthalmic Device Market, Taiwan, Revenue ($m), 2009-2016 49
  • Table 16: Ophthalmic Devices, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015 50
  • Table 17: Diagnostic Imaging Devices, Taiwan, Revenue ($m), 2009-2016 51
  • Table 18: Diagnostic Imaging Devices, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015 52
  • Table 19: Cardiovascular Device Market, Taiwan, Revenue ($m), 2009-2016 53
  • Table 20: Cardiovascular Device Market, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015 54
  • Table 21: Medical Device Market, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2012 55
  • Table 22: Medical Device Market, Osstem, Major Products, Global, 2016 66
  • Table 23: Medical Device Market, Nobel Biocare, Major Products, Global, 2016 67
  • Table 24: Medical Device Market, Ivoclar Vivadent, Major Products, Asia, 2017 71
  • Table 25: Market Access, Healthcare System, Taiwan, Premium Contribution Ratios under NHI System, 2016 85
  • Table 26: Market Access, Healthcare System, Taiwan, Basic Outpatient Care Co-payments ($), 2016 86
  • Table 27: Healthcare Expenditure, Taiwan, Out-of-Pocket Expenditure (%), 2009-2016 88
  • Table 28: Market Access, Taiwan, Healthcare Consumer Price Index Annual Change (%), 2009-2016 88
  • Table 29: Healthcare System, Taiwan, Registration Fee Structure for New Drug Application ($), 2017 95
  • Table 30: Healthcare System, Taiwan, Regulatory Requirement for Medical Devices, 2013 97
  • Table 31: Healthcare System, Taiwan, Medical Equipment Classification, 2016 97
  • Table 32: Healthcare System, Taiwan, Schedule of Patent Fees, 2017 106
  • Table 33: Market Access, Taiwan, Schedule of Trademark Fees, 2017 107
  • Table 34: Economic Indicators, Taiwan, GDP per Capita ($), 2009-2016 119
  • Table 35: Economic Indicators, Taiwan, GDP per Capita ($), 2017-2021 119
  • Table 36: Economic Indicators, Taiwan, GDP Annual Growth (%), 2009-2016 120
  • Table 37: Economic Indicators, Taiwan, GDP Annual Growth (%), 2017-2021 121
  • Table 38: Economic Indicators, Taiwan, GNI per Capita ($), 2009-2016 122
  • Table 39: Economic Indicators, Taiwan, Consumer Price Index, 2009-2016 123
  • Table 40: Economic Indicators, Taiwan, Average Consumer Price Index, 2017-2021 124
  • Table 41: Economic Indicators, Taiwan, Average Consumer Price Index Annual Change (%), 2009-2016 125
  • Table 42: Economic Indicators, Taiwan, Average Consumer Price Index, Annual Change (%), 2017-2021 126
  • Table 43: Economic Indicators, Taiwan, Currency Exchange Rate (TWD/$), 2009-2016 127
  • Table 44: Economic Indicators, Taiwan, Foreign Direct Investment ($bn), 2009-2016 128
  • Table 45: Economic Indicators, Taiwan, Foreign Exchange Reserves ($bn), 2009-2016 129
  • Table 46: Economic Indicators, Taiwan, Imports of Goods and Services ($bn), 2009-2016 130
  • Table 47: Economic Indicators, Taiwan, Exports of Goods and Services ($bn), 2009-2016 131
  • Table 48: Economic Indicators, Taiwan, General Government Structural Balance ($bn), 2009-2016 132
  • Table 49: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2009-2016 133
  • Table 50: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2017-2021 134
  • Table 51: Economic Indicators, Taiwan, Value Added by Major Industries ($bn), 2015 135
  • Table 52: Demographics, Taiwan, Population (million), 2009-2016 136
  • Table 53: Demographics, Taiwan, Population (million), 2017-2021 137
  • Table 54: Demographics, Taiwan, Urban-Rural Population Share (%), 2009-2016 138
  • Table 55: Demographics, Taiwan, Urban-Rural Population Share (%), 2017-2021 139
  • Table 56: Demographics, Taiwan, Population Distribution by Age Group (%), 2009-2016 140
  • Table 57: Demographics, Taiwan, Population Distribution by Age Group (%), 2017-2021 141
  • Table 58: Demographics, Taiwan, Births (per 1,000 Population), 2009-2016 142
  • Table 59: Demographics, Taiwan, Mortality (per 1,000 Population), 2009-2016 143
  • Table 60: Demographics, Taiwan, Major Causes of Mortality (%), 2015 144
  • Table 61: Demographics, Taiwan, Mortality Rate of Children Under One (per 1,000 live births), 2009-2016 145
  • Table 62: Demographics, Taiwan, Immunization Coverage (%), 2015 146
  • Table 63: Demographics, Taiwan, Gender Ratio (M/F), 2009-2016 147
  • Table 64: Demographics, Taiwan, Life Expectancy at Birth (years), 2009-2016 148
  • Table 65: Demographics, Taiwan, Life Expectancy at Birth (years), 2017-2021 149
  • Table 66: Demographics, Taiwan, Student Net Enrollment by Level of Education (%), 2016 150
  • Table 67: Demographics, Taiwan, Unemployment Rate (%), 2009-2016 151
  • Table 68: Demographics, Taiwan, Employment by Sector ('000), 2015 152
  • Table 69: Demographics, Taiwan, Personal Health Expenditure by Disease (%), 2014 153
  • Table 70: Healthcare Infrastructure, Taiwan, Hospitals, 2009-2016 154
  • Table 71: Healthcare Infrastructure, Taiwan, Public and Private Hospitals, 2009-2016 155
  • Table 72: Healthcare Infrastructure, Taiwan, Public Hospitals, Share by Ownership (%), 2015 156
  • Table 73: Healthcare Infrastructure, Taiwan, Private Hospitals, Share by Ownership (%), 2015 157
  • Table 74: Healthcare Infrastructure, Taiwan, Hospitals by Standard of Care, Contracted by NHIA, 2009-2016 158
  • Table 75: Healthcare Infrastructure, Taiwan, Hospitals by Services Rendered, 2015 159
  • Table 76: Healthcare Infrastructure, Taiwan, Beds by Type of Hospital, 2009-2016 160
  • Table 77: Healthcare Infrastructure, Taiwan, Beds by Specialty Care, 2015 161
  • Table 78: Healthcare Infrastructure, Taiwan, Diagnostic Centers, 2009-2016 162
  • Table 79: Healthcare Infrastructure, Taiwan, Hospitals Beds (per 10,000 population), 2009-2016 163
  • Table 80: Healthcare Infrastructure, Taiwan, Number of Doctors, 2009-2016 164
  • Table 81: Healthcare Infrastructure, Taiwan, CO2 Emissions (kilotons per year), 2009-2016 166
  • Table 82: Healthcare Infrastructure Taiwan, Nurses, 2009-2016 167
  • Table 83: Healthcare Infrastructure, Taiwan, Pharmacists, 2009-2016 168
  • Table 84: Healthcare Infrastructure, Taiwan, Dentists, 2009-2016 169
  • Table 85: Healthcare Infrastructure, Taiwan, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 170
  • Table 86: Healthcare Infrastructure, Taiwan, Public-Private Share of Expenditure (%), 2009-2016 171
  • Table 87: Healthcare Expenditure, Taiwan, Major Healthcare Trade Fairs, 2017 173

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009-2021 10
  • Figure 2: Medical Device Market, Taiwan, Revenue ($bn), 2009-2021 11
  • Figure 3: Country Profile, Taiwan, 2017 13
  • Figure 4: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009-2016 16
  • Figure 5: Pharmaceutical Market, Taiwan, Revenue ($bn), 2017-2021 17
  • Figure 6: Pharmaceutical Market, Taiwan, Exports and Imports ($bn), 2009-2016 18
  • Figure 7: Pharmaceutical Market, Taiwan, Revenue by Major Therapeutic Areas ($bn), 2014 22
  • Figure 8: Medical Device Market, Taiwan, Revenue ($bn), 2009-2016 42
  • Figure 9: Medical Device Market, Taiwan, Revenue ($bn), 2017-2021 43
  • Figure 10: Medical Device Market, Taiwan, Revenue by Segment ($m), 2016 44
  • Figure 11: Orthopedic Devices Market, Taiwan, Revenue ($m), 2009-2016 45
  • Figure 12: Orthopedic Devices Market, Taiwan, Market Share of Major Players (%), 2016 46
  • Figure 13: Healthcare IT Device Market, Taiwan, Revenue ($m), 2009-2016 47
  • Figure 14: Healthcare IT Device Market, Taiwan, Market Share of Major Players (%), 2015 48
  • Figure 15: Ophthalmic Device Market, Taiwan, Revenue ($m), 2009-2016 49
  • Figure 16: Ophthalmic Devices, Taiwan, Market Share of Major Players (%), 2015 50
  • Figure 17: Diagnostic Imaging Devices, Taiwan, Revenue ($m), 2009-2016 51
  • Figure 18: Diagnostic Imaging Devices, Taiwan, Market Share of Major Players (%), 2015 52
  • Figure 19: Cardiovascular Device Market, Taiwan, Revenue ($m), 2009-2016 53
  • Figure 20: Cardiovascular Device Market, Taiwan, Market Share of Major Players (%), 2016 54
  • Figure 21: Medical Device Market, Taiwan, Revenue of Major Players ($m), 2012 55
  • Figure 22: Healthcare Market, Taiwan, Drivers and Barriers, 2017 76
  • Figure 23: Market Access, Healthcare System, Taiwan, Organizational Structure of NHI, 2016 78
  • Figure 24: Market Access, Healthcare System, Taiwan, Evolution of Healthcare System, 2016 79
  • Figure 25: Market Access, Healthcare System, Taiwan, HTA Assessment for Application of NHI New Drug Listing, 2016 81
  • Figure 26: Market Access, Healthcare System, Taiwan, Process for Coverage and Reimbursement of Medical Devices, 2016 82
  • Figure 27: Market Access, Healthcare System, Taiwan, NHI System, 2016 83
  • Figure 28: Market Access, Healthcare System, Taiwan, Premium Collection under Second-Generation NHI System, 2016 84
  • Figure 29: Healthcare Expenditure, Taiwan, Out-of-Pocket Expenditure (%), 2009-2016 87
  • Figure 30: Market Access, Taiwan, Healthcare Consumer Price Index Annual Change (%), 2009-2016 88
  • Figure 31: Market Access, Taiwan, Organizational Structure of Center for Drug Evaluation, 2017 91
  • Figure 32: Market Access, Taiwan, Drug Review Process for NDA, 2017 95
  • Figure 33: Market Access, Taiwan, Total Product Life Cycle Management Process, 2017 96
  • Figure 34: Market Access, Taiwan, Marketing Authorization Procedure for Medical Devices, 2013 100
  • Figure 35: Market Access, Taiwan, IVD Registration Application Process, 2017 101
  • Figure 36: Market Access, Taiwan, Clinical Trial Regulation Process for an Investigational New Drug, 2014 109
  • Figure 37: Economic Indicators, Taiwan, GDP Per Capita ($), 2009-2016 118
  • Figure 38: Economic Indicators, Taiwan, GDP per Capita ($), 2017-2021 119
  • Figure 39: Economic Indicators, Taiwan, GDP Annual Growth (%), 2009-2016 120
  • Figure 40: Economic Indicators, Taiwan, GDP Annual Growth (%), 2017-2021 121
  • Figure 41: Economic Indicators, Taiwan, GNI per Capita ($), 2009-2016 122
  • Figure 42: Economic Indicators, Taiwan, Consumer Price Index, 2009-2016 123
  • Figure 43: Economic Indicators, Taiwan, Average Consumer Price Index, 2017-2021 124
  • Figure 44: Economic Indicators, Taiwan, Average Consumer Price Index, Annual Change (%), 2009-2016 125
  • Figure 45: Economic Indicators, Taiwan, Average Consumer Price Index, Annual Change (%), 2017-2021 126
  • Figure 46: Economic Indicators, Taiwan, Currency Exchange Rate (TWD/$), 2009-2016 127
  • Figure 47: Economic Indicators, Taiwan, Foreign Direct Investment ($bn), 2009-2016 128
  • Figure 48: Economic Indicators, Taiwan, Foreign Exchange Reserves ($bn), 2009-2016 129
  • Figure 49: Economic Indicators, Taiwan, Imports of Goods and Services ($bn), 2009-2016 130
  • Figure 50: Economic Indicators, Taiwan, Exports of Goods and Services ($bn), 2009-2016 131
  • Figure 51: Economic Indicators, Taiwan, Government Structural Balance ($bn), 2009-2016 132
  • Figure 52: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2009-2016 133
  • Figure 53: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2017-2021 134
  • Figure 54: Economic Indicators, Taiwan, Value Added by Major Industries ($bn), 2015 135
  • Figure 55: Demographics, Taiwan, Population (million), 2009-2016 136
  • Figure 56: Demographics, Taiwan, Population (million), 2017-2021 137
  • Figure 57: Demographics, Taiwan, Urban-Rural Population Share (%), 2009-2016 138
  • Figure 58: Demographics, Taiwan, Urban-Rural Population Share (%), 2017-2021 139
  • Figure 59: Demographics, Taiwan, Population Distribution by Age Group (%), 2009-2016 140
  • Figure 60: Demographics, Taiwan, Population Distribution by Age Group (%), 2017-2021 141
  • Figure 61: Demographics, Taiwan, Births (per 1,000 Population), 2009-2016 142
  • Figure 62: Demographics, Taiwan, Mortality (per 1,000 Population), 2009-2016 143
  • Figure 63: Demographics, Taiwan, Major Causes of Mortality (%), 2015 144
  • Figure 64: Demographics, Taiwan, Mortality Rate of Children Under One (per 1,000 live births), 2009-2016 145
  • Figure 65: Demographics, Taiwan, Immunization Coverage (%), 2015 146
  • Figure 66: Demographics, Taiwan, Gender Ratio (M/F), 2009-2016 147
  • Figure 67: Demographics, Taiwan, Life Expectancy at Birth (years), 2009-2016 148
  • Figure 68: Demographics, Taiwan, Life Expectancy at Birth (years), 2017-2021 149
  • Figure 69: Demographics, Taiwan, Student Net Enrollment by Level of Education (%), 2016 150
  • Figure 70: Demographics, Taiwan, Unemployment Rate (%), 2009-2016 151
  • Figure 71: Demographics, Taiwan, Employment by Sector ('000), 2015 152
  • Figure 72: Demographics, Taiwan, Personal Health Expenditure by Disease (%), 2014 153
  • Figure 73: Healthcare Infrastructure, Taiwan, Hospitals, 2009-2016 154
  • Figure 74: Healthcare Infrastructure, Taiwan, Public and Private Hospitals, 2009-2016 155
  • Figure 75: Healthcare Infrastructure, Taiwan, Public Hospitals, Share by Ownership (%), 2015 156
  • Figure 76: Healthcare Infrastructure, Taiwan, Private Hospitals, Share by Ownership (%), 2015 157
  • Figure 77: Healthcare Infrastructure, Taiwan, Hospitals by Standard of Care, Contracted by NHIA, 2009-2016 158
  • Figure 78: Healthcare Infrastructure, Taiwan, Hospitals by Services Rendered (%), 2015 159
  • Figure 79: Healthcare Infrastructure, Taiwan, Beds by Type of Hospital, 2009-2016 160
  • Figure 80: Healthcare Infrastructure, Taiwan, Beds by Specialty Care, 2015 161
  • Figure 81: Healthcare Infrastructure, Taiwan, Diagnostic Centers, 2009-2016 162
  • Figure 82: Healthcare Infrastructure, Taiwan, Hospitals Beds (per 10,000 population), 2009-2016 163
  • Figure 83: Healthcare Infrastructure, Taiwan, Number of Doctors, 2009-2016 164
  • Figure 84: Healthcare Infrastructure, Taiwan, CO2 Emissions (kilotons per year), 2009-2016 166
  • Figure 85: Healthcare Infrastructure, Taiwan, Nurses, 2009-2016 167
  • Figure 86: Healthcare Infrastructure, Taiwan, Pharmacists, 2009-2016 168
  • Figure 87: Healthcare Infrastructure, Taiwan, Dentists, 2009-2016 169
  • Figure 88: Healthcare Infrastructure, Taiwan, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 170
  • Figure 89: Healthcare Infrastructure, Taiwan, Public-Private Share of Expenditure (%), 2009-2016 171
  • Figure 90: Healthcare Market, Taiwan, Opportunities and Challenges, 2017 175
Back to Top